Barclays PLC Novo Cure LTD Call Options Transaction History

Barclays PLC

  • $357 Billion
  • Q4 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$14.54 - $33.41 $436,200 - $1 Million
30,000 New
30,000 $894,000
Q1 2024

May 15, 2024
BUY
$12.42 - $17.29 $3.73 Million - $5.19 Million
300,000 New
300,000 $4.69 Million
Q3 2020

Nov 12, 2020
BUY
$58.05 - $111.31 $452,790 - $868,218
7,800 Added 45.61%
24,900 $2.77 Million
Q1 2020

May 13, 2020
BUY
$57.05 - $95.75 $975,555 - $1.64 Million
17,100 New
17,100 $1.15 Million

Others Institutions Holding NVCR

# of Institutions
290
Shares Held
75.2M
Call Options Held
1.81M
Put Options Held
464K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.36B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email